SCHEMBL10090226

SCHEMBL10090226

O=C1NC(=S)S/C1=C\c1cc(Cl)ccc1[N+](=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTP4A3 O75365 3/20 0.68
▸ CRHBP P24387 2/20 0.68
▸ CRHR2 Q13324 2/20 0.68
▸ PLA2G1B P04054 1/20 0.58
▸ ATG4B Q9Y4P1 1/20 0.58
▸ NAT1 P18440 4/20 0.56
▸ MYC P01106 1/20 0.56
▸ MAX P61244 1/20 0.56
▸ DNM1 Q05193 1/20 0.53
▸ PIM1 P11309 1/20 0.53
▸ MGAM O43451 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ SI P14410 1/20 0.51
▸ MGAM2 Q2M2H8 1/20 0.51
▸ CISD1 Q9NZ45 1/20 0.50
▸ GSK3B P49841 2/20 0.48
▸ MEN1 O00255 1/20 0.47
▸ PSMD14 O00487 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14610176 0.89 PTP4A3 (0.70) PTP4A3CRHBPCRHR2PLA2G1BATG4B
SCHEMBL2065487 0.88 CRHBP (0.72) PTP4A3CRHBPCRHR2PLA2G1BATG4B
SCHEMBL2065485 0.88 CRHBP (0.72) PTP4A3CRHBPCRHR2PLA2G1BATG4B
SCHEMBL18102858 0.82 PTP4A3 (0.75) PTP4A3CRHBPCRHR2PLA2G1BATG4B
SCHEMBL28965550 0.81 PTP4A3 (1.00) PTP4A3CRHBPCRHR2PLA2G1BATG4B
SCHEMBL13499573 0.80 CRHBP (0.68) PTP4A3CRHBPCRHR2PLA2G1BATG4B
SCHEMBL14899471 0.79 PTP4A3 (0.75) PTP4A3CRHBPCRHR2PLA2G1BATG4B
SCHEMBL18102957 0.79 PTP4A3 (0.71) PTP4A3CRHBPCRHR2PLA2G1BATG4B
SCHEMBL12204299 0.79 PTP4A3 (0.79) PTP4A3CRHBPCRHR2PLA2G1BATG4B
SCHEMBL20535130 0.79 PTP4A3 (0.79) PTP4A3CRHBPCRHR2PLA2G1BATG4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148541-B2 Rhodanine derivatives, a process for the preparation thereof and pharmaceutical composition containing the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2012-04-03 — — US disclosed
US-20090042872-A1 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-02-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042872-A1 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same PTPRR, PTPRG, PTPRS PTP4A3 28/4885CRHBP 480/4885CRHR2 1251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback